As demonstrated by multi-variant COX regression analysis in Tables S2, TET2 could still affect the prognosis of patients, even when the effects of tumor stage, lymph node metastasis and distant metastasis were excluded (Supplementary Table S2). Here, TET2 is linked to metastatic malignant neoplasm in the lymph nodes.